Tommy Nørskov Johansen

Dr. Tommy Nørskov Johansen

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2002 in Molecular Pharmacology
Verified
Journal Article
Closed access
PDF file
AJAnders A. Jensen
Anders A. Jensen
JMJohannes Mosbacher
Johannes Mosbacher
SESusanne Elg
Susanne Elg
KLKurt Lingenhoehl
Kurt Lingenhoehl
TLTania Lohmann
Tania Lohmann
HBHans Bräuner-Osborne
Hans Bräuner-Osborne
The actions of the anticonvulsant gabapentin [1-(aminomethyl)cyclohexaneacetic acid, Neurontin] have been somewhat enigmatic until recently, when it was claimed to be a γ-aminobutyric acid-B (GABAB) receptor agonist acting exclusively at a heterodimeric complex containing the GABAB(1a) splice variant (Mol Pharmacol2001;59:144–152). In this study, we have investigated the effects of gabapentin on recombinant GABAB(1a)and GABAB(1b) receptors coexpressed with GABAB(2) in five different functional recombinant assays, its ability to inhibit [3H]GABA binding in a GABAB receptor-selective binding assay using rat synaptic membranes, and its ability to inhibit transient lower esophageal sphincter relaxations in Labrador retriever dogs. Up to a concentration of 1 mM, gabapentin displayed no agonistic effects on either the GABAB(1a,2) or the GABAB(1b,2) heterodimer, when these were expressed in Xenopus laevis oocytes or mammalian cells and assayed by means of electrophysiology, calcium mobilization, inositol phosphate, and fluorometry assays. Gabapentin did not displace [3H]GABA from GABABreceptor sites in rat synaptic membranes. Finally, in contrast to the classic GABAB receptor agonist baclofen, gabapentin was unable to inhibit transient lower esophageal sphincter relaxations in dogs. Because of high levels of GABAB(1a) in the canine nodose ganglion, this finding indirectly supports the inactivity of gabapentin on the GABAB(1a,2) heterodimer demonstrated in various in vitro assays. In light of these results, we find it highly questionable that gabapentin is a GABAB receptor agonist. Hence, the anticonvulsive effects of the compound have to arise from GABAB receptor-independent mechanisms. This also implies that the first GABAB receptor splice variant-selective ligand remains to be discovered.

18 April 2008 in Chemical Research in Toxicology
Verified
Journal Article
Closed access
KMKim G. Madsen
Kim G. Madsen
CSChristian Skonberg
Christian Skonberg
UJUlrik Jurva
Ulrik Jurva
CCClaus Cornett
Claus Cornett
SHSteen H. Hansen
Steen H. Hansen
JOJørgen Olsen
Jørgen Olsen

16 September 2010 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MCMette K. Christensen
Mette K. Christensen
KEKamille D. Erichsen
Kamille D. Erichsen
CTChristina Trojel-Hansen
Christina Trojel-Hansen
JTJette Tjørnelund
Jette Tjørnelund
SNSøren J. Nielsen
Søren J. Nielsen
FBFredrik Björkling
Fredrik Björkling

5 April 2021 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JPJakob S. Pallesen
Jakob S. Pallesen
DNDilip Narayanan
Dilip Narayanan
KTKim T. Tran
Kim T. Tran
SSSara M. Ø. Solbak
Sara M. Ø. Solbak
GMGiuseppe Marseglia
Giuseppe Marseglia
ABAnders Bach
Anders Bach

1 October 1997 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
HAHaleh Ahmadian
Haleh Ahmadian
BNBirgitte Nielsen
Birgitte Nielsen
HBHans Bräuner-Osborne
Hans Bräuner-Osborne
TJTommy Nørskov Johansen
Tommy Nørskov Johansen
TSTine B. Stensbøl
Tine B. Stensbøl
UMUlf Madsen
Ulf Madsen

1 March 2008 in Tetrahedron
Verified
Journal Article
Closed access
SLSimon Birksø Larsen
Simon Birksø Larsen
Benny Bang-AndersenBenny Bang-Andersen
Benny Bang-Andersen
TJTommy Nørskov Johansen
Tommy Nørskov Johansen
MJMorten Jørgensen
Morten Jørgensen